Home Editor's Pick CLEO Further Expands Ovarian Cancer Trial with Siles Health
Editor's Pick

CLEO Further Expands Ovarian Cancer Trial with Siles Health

by admin

Cleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles Health

Download the PDF here.

This post appeared first on investingnews.com

You may also like

SAGA Metals Announces Closing of $700,000 Private Placement...

5 Best-performing Canadian Oil and Gas Stocks in...

Lode Gold Announces $350,000 Non-Brokered Financing

Metals Australia

Cannabis Market 2024 Year-End Review

5 Best-performing Junior Copper Stocks on the TSXV...

Completion of QSM Acquisition

Don Hansen: Gold, Silver Stocks “Extraordinarily Undervalued,” Data...

Fortune Minerals Announces Second Draw From Convertible Securities...

Element79 Announces Payment Extension Agreement for Lucero Project